Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo

Journal of the American College of Cardiology

Volumn 23, Issue 4, 1994, Pages 961-969

  Fatkin, Diane ^a   Kelly, Raymond P ^a   Feneley, Michael P ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; WARFARIN;

ARTICLE; BLOOD FLOW VELOCITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSIS; DRUG THERAPY; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; THROMBOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; BLOOD FLOW VELOCITY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOEMBOLISM; THROMBOSIS;

EID: 0028325925     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)90644-0     Document Type: Article

References (35)

1. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance
2. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk
3. Intra-atrial smoke-like echoes and thrombi formation
4. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography
5. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis
6. Clinical implications of left atrial spontaneous echo contrast in non-rheumatic atrial fibrillation
7. Left atrial spontaneous contrast echoes—markers of thromboembolic risk in patients with atrial fibrillation
8. Ultrasonography of blood during stasis and coagulation
9. The direct visualisation of blood flow by real-time ultrasound: clinical observations and underlying mechanisms
10. Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis
11. Echocardiographic “smoke” is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces
12. Cyclic changes of blood echogenicity in high frequency ultrasound
13. Mural thrombosis and arterial embolism in mitral stenosis: a clinicopathologic study of 51 cases
14. Two-dimensional echocardiographic diagnosis of left atrial thrombus in rheumatic heart disease: a clinicopathologic study
15. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus
16. Left atrial appendage dysfunction: a cause of thrombosis? Evidence by transesophageal echocardiography-Doppler studies
17. Left atrial appendage Doppler flow patterns: implications on thrombus formation
18. Left atrial appendage flow velocity assessment using transesophageal echocardiography in non-rheumatic atrial fibrillation and systemic embolism
19. Recommendations regarding quantitation in M-mode echocardiography. results of a survey of echocardiographic measurements
20. Transesophageal echocardiography: technique, anatomic correlations, implementation, and clinical applications
21. Physics of blood echogenicity
22. The effects of hematocrit, shear rate and turbulence on ultrasound Dopper spectrum from blood
23. The relation between intracardiovascular smoke-like echo and erythrocyte rouleaux formation
24. The effects of heparin versus citrate on blood echogenicity in vitro: the role of platelet and platelet-neutrophil aggregates
25. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling
26. Non-invasive estimation of valve area in patients with aortic stenosis by Dopoler ultrasound and two-dimensional echocardiography
27. Formation of left atrial spontaneous echocardiographic contrast after surgical correction of mitral regurgitation
28. Left ventricular thrombi and cerebral embolism
29. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
30. The effect of low-dose warfarin on the risk of stroke in non-rheumatic atrial fibrillation
31. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
32. Predictors of thromboembolism in atrial fibrillation I Clinical features of patients at risk
33. Predictors of thromboembolism in atrial fibrillation II Echocardiographic features of patients at risk
34. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in non-valvular atrial fibrillation